HOME >> MEDICINE >> NEWS
Children need 60 minutes of daily physical activity, expert panel says

School-age children should participate in 60 minutes or more of moderate to vigorous physical activity daily, according to an expert panel.

"The take-home message for parents is that it is very important to ensure that their children spend at least an hour a day in some form of appropriate physical activity," says Dr. William B. Strong, a pediatric cardiologist and retired professor at the Medical College of Georgia who co-chaired the panel.

"The important thing is we have to get American children and adolescents active," says co-chair Dr. Robert M. Malina, research professor and an expert in growth and development at Tarleton State University in Stephenville, Texas. "The evidence is very clear that physical activity has decreased dramatically in the last 10 to 20 years," Dr. Malina says as the technology revolution of the 1980s produced more sedentary options for children while their caloric intake has essentially remained the same.

"Our children are just not burning up those calories today," Dr. Malina says of the obesity epidemic in children. "All of us need to help children increase the amount of time spent in moderate to vigorous physical activity. This means that parents, coaches, teachers and others who influence youngsters need to become active role models and get children involved with regular participation in physical activity."

"Increasing the level of habitual moderate to vigorous intensity physical activity in youth is a health promotion and a disease prevention strategy," the panelists conclude. Restoration of physical education and other school- and community-based programs could contribute mightily to that strategy, they say. Recommendations of the 13-member panel are published in the June issue of The Journal of Pediatrics. Panelists were convened by the Constella Group, Inc., a professional health services company headquartered in Durham, N.C., contracted by the Divisions of Nutrition and Physical Activity and Adol
'"/>

Contact: Toni Baker, Medical College of Georgia
tbaker@mcg.edu
706-721-4421
Elsevier Health Sciences
13-Jun-2005


Page: 1 2 3 4

Related medicine news :

1. Support for Childrens Health and Medicare Protection Act given to House leaders by ACP
2. Children and young people show elevated leukaemia rates near nuclear facilities
3. Childrens brain responses predict impact of sleep loss on attention
4. Children with sleep disorder symptoms are more likely to have trouble academically
5. USC and Childrens Hospital Los Angeles both receive grants for stem cell facilities
6. Children with both autism and ADHD often bully, parents say
7. Childrens Hospital and Pitt lead national trial of hypothermia to treat pediatric brain injury
8. A frown or a smile? Children with autism cant discern
9. Children from low income families more likely to have sleep problems
10. Childrens Hospital Boston presents at the American College of Cardiology Scientific Sessions
11. Children with attention deficit hyperactivity disorder at risk for alcohol problems

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Children need minutes daily physical activity expert panel says

(Date:5/21/2013)... York (PRWEB) May 21, 2013 The ... Conserve hip replacement lawsuits in U.S. District ... in response to a request from Plaintiffs’ Counsel to ... Defendant. The May 17th Order grants that request, ... be conducted. (In re: Wright Medical Technology, Inc., Conserve ...
(Date:5/21/2013)... MedMar Healing Center announces their participation ... Food Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and ... The goal is to raise food to help area kids ... families in recent years. , “We like being able ... need,” explains Douglas Chloupek of MedMar Healing Center. “Taking part ...
(Date:5/21/2013)... Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers ... disease (IBD), which could help with earlier diagnosis and ... , This finding, the first of its kind and ... via podium presentation by staff from Walter Reed National ... held May 18-21 in Orlando, Fla. , The ...
(Date:5/21/2013)... 21, 2013 Today, Zane Benefits, Inc. ... FSA accounts. Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... , According to Zane Benefits’ website, the Affordable Care ... into law in 2010 and impacts many areas of ...
(Date:5/21/2013)... May 21, 2013 The American Diabetes ... people in the United States of America are affected ... at a great risk of developing peripheral neuropathy which ... lives. The ADA further goes on saying that the ... and around 2 million new cases are diagnosed every ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2
(Date:5/21/2013)... N.Y. , May 21, 2013 Sanofi ... (NASDAQ: REGN) today announced that the New England ... 2a study results of dupilumab (SAR231893/REGN668) in patients with ... targeting the alpha subunit of the interleukin 4 receptor ... IL-13, drivers of Th2 (Type 2 helper T cell) ...
(Date:5/21/2013)... May 21, 2013 U.S. spending on specialty ... diseases such as cancer, multiple sclerosis and rheumatoid arthritis ... end of 2015, according to a forecast released today ... http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) "As we see ... health plans to act so they can continue to ...
(Date:5/21/2013)... CITY, Calif. , May 21, 2013 ... ACRX ), a specialty pharmaceutical company focused ... therapies for the treatment of acute and ... that in a placebo-controlled Phase 3 study ... (patient-controlled analgesia) System (NanoTab System), the primary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
Cached News: